Cindy Boer

192 | Chapter 4.1 The deCODE genetics osteoarthritis study: We thank the study subjects for their valu- able participation. HUNT study: The genotyping was financed by the National Institute of health (NIH), University of Michigan, The Norwegian Research council, and Central Norway Regional Health Authority and the Faculty of Medicine and Health Sciences, Norwegian Universi- ty of Science and Technology (NTNU). The genotype quality control and imputation has been conducted by the K.G. Jebsen center for genetic epidemiology, Department of pub- lic health and nursing, Faculty of medicine and health sciences, Norwegian University of Science and Technology (NTNU). GARP: We thank all study participants of the GARP study. Leiden University Medical Centre, Pfizer Groton, Connecticut, USA and the Dutch Arthritis Society have supported the GARP study. Furthermore, the research leading to these results has received funding from the Biobanking and BioMolecular resources Research Infrastructure the Nether- lands (BBMRI-NL) (complementation project CP2013-84), and the Dutch Arthritis So- ciety (DAF_10_1-402). We are indebted to drs. N. Riyazi, J. Bijsterbosch, H.M. Kroon and I. Watt for collection of data. RAAK: We thank all study participants of the RAAK study. The Leiden University Medical Centre have and are supporting the RAAK. We thank Evelyn Houtman, Enrike van der Linden, Robert van der Wal, Peter van Schie, Shaho Hasan, Maartje Meijer, Daisy Latijn- houwers, Anika Rabeling-Hoogenstraaten, and Geert Spierenburg for their contribution to the collection of the joint tissue. Furthermore, the research leading to these results has received funding from the: TreatOA which is funded by the European Commission framework 7 programme grant 200800. BBMRI Metabolomics Consortium funded by BBMRI-NL, a research infrastructure financed by the Dutch government (NWO, grant nr 184.021.007 and 184033111). Dutch Scientific Research council NWO /ZonMW VICI scheme ( 91816631/528) The Leiden Longevity Study has received funding from the European Union’s Seventh Framework Programme (FP7/2007-2011) under grant agreement number 259679. This study was financially supported by the Innovation-Oriented Research Program on Genomics (SenterNovem IGE05007), the Centre for Medical Systems Biology and the Netherlands Consortium for Healthy Ageing (grant 050-060-810), all in the frame- work of the Netherlands Genomics Initiative, Netherlands Organization for Scientific Research (NWO), and by BBMRI-NL, a Research Infrastructure financed by the Dutch government (NWO 184.021.007 and 184033111). This work is supported by the re- search programme VOILA with project number 457001001, which is (partly) financed by ZonMw (The Netherlands Organization for Health Research and Development).